CD95(Fas/APO-1) Signals Ceramide Generation Independent of the Effector Stage of Apoptosis*

Although numerous studies document caspase-independent ceramide generation preceding apoptosis upon environmental stress, the molecular ordering of ceramide generation during cytokine-induced apoptosis remains uncertain. Here, we show that CD95-induced ceramide elevation occurs during the initiation phase of apoptosis. We titrated down the amount of FADD transfected into HeLa and 293T cells until it was insufficient for apoptosis, although cycloheximide (CHX) still triggered the effector phase. Even in the absence of CHX, ceramide levels increased rapidly, peaking at 2.7 ± 0.2-fold of control 8 h post-transfection. Dominant negative FADD failed to confer ceramide generation or CHX-mediated apoptosis. Ceramide generation induced by FADD was initiator caspase-dependent, being blocked by crmA. Limited pro-caspase 8 overexpression also increased ceramide levels 2.7 ± 0.2-fold, yet failed, without CHX, to initiate apoptosis. Expression of membrane-targeted oligomerized CD-8 caspase 8 induced apoptosis without CHX, yet elevated ceramide only to a level equivalent to limited pro-caspase 8 transfection. Ceramide elevations were detected concurrently by diacylglycerol kinase and electrospray tandem mass spectrometry. These investigations provide evidence that ceramide generation is initiator caspase-dependent and occurs prior to commitment to the effector phase of apoptosis, definitively ordering ceramide as proximal in CD95 signaling.

[1]  Ingo Schmitz,et al.  Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells* , 1999, The Journal of Biological Chemistry.

[2]  M. Clanet,et al.  Involvement of de novo ceramide biosynthesis in lymphotoxin-induced oligodendrocyte death. , 1999, Neuroreport.

[3]  S. Payne,et al.  Epidermal growth factor inhibits ceramide‐induced apoptosis and lowers ceramide levels in primary placental trophoblasts , 1999, Journal of cellular physiology.

[4]  C. Rodolfo,et al.  Ceramide accumulation precedes caspase-dependent apoptosis in CHP-100 neuroepithelioma cells exposed to the protein phosphatase inhibitor okadaic acid , 1999, Cell Death and Differentiation.

[5]  W. V. van Blitterswijk,et al.  Common Regulation of Apoptosis Signaling Induced by CD95 and the DNA-damaging Stimuli Etoposide and γ-Radiation Downstream from Caspase-8 Activation* , 1999, The Journal of Biological Chemistry.

[6]  J C Reed,et al.  Caspase-9 Can Be Activated without Proteolytic Processing* , 1999, The Journal of Biological Chemistry.

[7]  J. Pfeilschifter,et al.  Nitric Oxide Donors Induce Stress Signaling via Ceramide Formation in Rat Renal Mesangial Cells* , 1999, The Journal of Biological Chemistry.

[8]  T. Mak,et al.  Requirement of FADD for Tumor Necrosis Factor-induced Activation of Acid Sphingomyelinase* , 1999, The Journal of Biological Chemistry.

[9]  R. Aebersold,et al.  On the complexities of ceramide changes in cells undergoing apoptosis: lack of evidence for a second messenger function in apoptotic induction , 1999, Cell Death and Differentiation.

[10]  N. Karasavvas,et al.  Relationships of apoptotic signaling mediated by ceramide and TNF-α in U937 cells , 1999, Cell Death and Differentiation.

[11]  A E Giuliano,et al.  Expression of Glucosylceramide Synthase, Converting Ceramide to Glucosylceramide, Confers Adriamycin Resistance in Human Breast Cancer Cells* , 1999, The Journal of Biological Chemistry.

[12]  S. Korsmeyer,et al.  Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways , 1998, Nature Medicine.

[13]  R. Kolesnick,et al.  Signal transduction of stress via ceramide. , 1998, The Biochemical journal.

[14]  J. Abrams,et al.  Ceramide Generation by the Reaper Protein Is Not Blocked by the Caspase Inhibitor, p35* , 1998, The Journal of Biological Chemistry.

[15]  K. Hofmann,et al.  Ceramide in apoptosis--does it really matter? , 1998, Trends in biochemical sciences.

[16]  A. Windebank,et al.  Suramin induced ceramide accumulation leads to apoptotic cell death in dorsal root ganglion neurons , 1998, Cell Death and Differentiation.

[17]  D. Ferrari,et al.  Differential Regulation and ATP Requirement for Caspase-8 and Caspase-3 Activation during CD95- and Anticancer Drug–induced Apoptosis , 1998, The Journal of experimental medicine.

[18]  A. Giaccia,et al.  Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress. , 1998, Genes & development.

[19]  D. Choi,et al.  Involvement of de Novo Ceramide Biosynthesis in Tumor Necrosis Factor-α/Cycloheximide-induced Cerebral Endothelial Cell Death* , 1998, The Journal of Biological Chemistry.

[20]  Y. Hannun,et al.  Increases in neutral, Mg2+-dependent and acidic, Mg2+-independent sphingomyelinase activities precede commitment to apoptosis and are not a consequence of caspase 3-like activity in Molt-4 cells in response to thymidylate synthase inhibition by GW1843. , 1998, Blood.

[21]  S. Nakashima,et al.  Ceramide Formation Leads to Caspase-3 Activation during Hypoxic PC12 Cell Death , 1998, The Journal of Biological Chemistry.

[22]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[23]  M. Krönke,et al.  TNF Receptor Death Domain-associated Proteins TRADD and FADD Signal Activation of Acid Sphingomyelinase* , 1998, The Journal of Biological Chemistry.

[24]  S. Pillai,et al.  Inhibition of caspase activity prevents anti-IgM induced apoptosis but not ceramide generation in WEHI 231 B cells. , 1998, Molecular immunology.

[25]  R. Siegel,et al.  Membrane Oligomerization and Cleavage Activates the Caspase-8 (FLICE/MACHα1) Death Signal* , 1998, The Journal of Biological Chemistry.

[26]  A. Giuliano,et al.  Glucosylceramide: a marker for multiple-drug resistant cancers. , 1998, Anticancer research.

[27]  C. Cordon-Cardo,et al.  Lipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation , 1997, The Journal of experimental medicine.

[28]  M. Peter,et al.  FLICE Is Predominantly Expressed as Two Functionally Active Isoforms, Caspase-8/a and Caspase-8/b* , 1997, The Journal of Biological Chemistry.

[29]  I. Herr,et al.  Activation of CD95 (APO‐1/Fas) signaling by ceramide mediates cancer therapy‐induced apoptosis , 1997, The EMBO journal.

[30]  W. V. van Blitterswijk,et al.  The role of ceramide in apoptosis , 2000 .

[31]  M. Nikolova-Karakashian,et al.  Bimodal Regulation of Ceramidase by Interleukin-1β , 1997, The Journal of Biological Chemistry.

[32]  R. Aebersold,et al.  Fas-induced apoptosis of T cells occurs independently of ceramide generation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G. Kroemer,et al.  The Central Executioner of Apoptosis: Multiple Connections between Protease Activation and Mitochondria in Fas/APO-1/CD95- and Ceramide-induced Apoptosis , 1997, The Journal of experimental medicine.

[34]  A. Suzuki,et al.  Sequential operation of ceramide synthesis and ICE cascade in CPT-11-initiated apoptotic death signaling. , 1997, Experimental cell research.

[35]  D. Green,et al.  The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[36]  Y. Hannun,et al.  Cytokine Response Modifier A (CrmA) Inhibits Ceramide Formation in Response to Tumor Necrosis Factor (TNF)-α: CrmA and Bcl-2 Target Distinct Components in the Apoptotic Pathway , 1997, The Journal of experimental medicine.

[37]  A. W. Murray,et al.  Ceramide induces apoptosis in PC12 cells , 1997, FEBS letters.

[38]  A. Giuliano,et al.  Agents that Reverse Multidrug Resistance, Tamoxifen, Verapamil, and Cyclosporin A, Block Glycosphingolipid Metabolism by Inhibiting Ceramide Glycosylation in Human Cancer Cells* , 1997, The Journal of Biological Chemistry.

[39]  Y. Hannun Functions of Ceramide in Coordinating Cellular Responses to Stress , 1996, Science.

[40]  A E Giuliano,et al.  Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells* , 1996, The Journal of Biological Chemistry.

[41]  Seamus J. Martin,et al.  Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis , 1996, Cell.

[42]  Xiaodong Wang,et al.  Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[43]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[44]  L. Zon,et al.  Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis , 1996, Nature.

[45]  A. Chinnaiyan,et al.  FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis (*) , 1996, The Journal of Biological Chemistry.

[46]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[47]  K. Scotto,et al.  Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals , 1995, Cell.

[48]  Patrick R. Griffin,et al.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.

[49]  Arul M. Chinnaiyan,et al.  FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.

[50]  M. Tewari,et al.  Fas- and Tumor Necrosis Factor-induced Apoptosis Is Inhibited by the Poxvirus crmA Gene Product (*) , 1995, The Journal of Biological Chemistry.

[51]  Y. Hirabayashi,et al.  Induction of apoptotic DNA fragmentation and cell death by natural ceramide , 1995, FEBS letters.

[52]  R. Testi,et al.  Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase , 1994, The Journal of experimental medicine.

[53]  W. Bursch,et al.  Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.